Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization (Q35064105)

6 August 2017

Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization (English)

1 reference

6 August 2017

1 reference

hepatic encephalopathy

1 reference

17

Jasmohan S Bajaj

1 reference

6 August 2017

Kavish R Patidar

1

1 reference

6 August 2017

Leroy R Thacker

2

1 reference

6 August 2017

James B Wade

3

1 reference

6 August 2017

Richard K Sterling

4

1 reference

6 August 2017

Arun J Sanyal

5

1 reference

6 August 2017

Mohammad S Siddiqui

6

1 reference

6 August 2017

Scott C Matherly

7

1 reference

6 August 2017

R Todd Stravitz

8

1 reference

6 August 2017

Puneet Puri

9

1 reference

6 August 2017

Velimir A Luketic

10

1 reference

6 August 2017

Michael Fuchs

11

1 reference

6 August 2017

Melanie B White

12

1 reference

6 August 2017

Nicole A Noble

13

1 reference

6 August 2017

Ariel B Unser

14

1 reference

6 August 2017

HoChong Gilles

15

1 reference

6 August 2017

Douglas M Heuman

16

1 reference

6 August 2017

language of work or name

English

0 references

publication date

2 September 2014

1 reference

The American Journal of Gastroenterology

6 August 2017

1 reference

6 August 2017

109

1 reference

6 August 2017

11

1 reference

6 August 2017

1757-1763

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2014.264

6 August 2017

0 references

cites work

Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Covert hepatic encephalopathy: not as minimal as you might think

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Linkage of gut microbiome with cognition in hepatic encephalopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Rifaximin treatment in hepatic encephalopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Role of ammonia and inflammation in minimal hepatic encephalopathy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321782

A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy

16 November 2018

1 reference

12 December 2020

Prognostic benefit of the addition of a quantitative index of hepatic encephalopathy to the MELD score: the MELD-EEG

1 reference

12 December 2020

Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

1 reference

12 December 2020

Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy

1 reference

12 December 2020

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

1 reference

12 December 2020

The prognostic significance of subclinical hepatic encephalopathy

1 reference

12 December 2020

Testing for minimal hepatic encephalopathy in the United States: An AASLD survey

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2014.264

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference